Skip to main content
A
NYSE Life Sciences

Agilent Raises $600M via 4.900% Senior Notes Due 2032 in Private Offering

Reported by Wiseek News · Tom Rudovsky
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$135.51
Mkt Cap
$38.272B
52W Low
$108.35
52W High
$160.27
52W Position info
25% above low
Off High info
15% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

A sits 25% above its 52-week low of $108.35.

Summary

Agilent Technologies completed a $600 million private offering of 4.900% Senior Notes due 2032. This debt financing provides the company with long-term capital at a fixed rate. The offering impacts Agilent's capital structure and liquidity, securing funds for general corporate purposes.

At the time of this announcement, A was trading at $135.51 on NYSE in the Life Sciences sector, with a market capitalization of approximately $38.3B. The 52-week trading range was $108.35 to $160.27. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Wiseek News.

Price Chart

Share this article

Copied!

A - Latest Insights

A
Jun 25, 2026, 4:33 PM EDT
Source: Wiseek News
Importance Score:
7
Agilent Raises $600M via 4.900% Senior Notes Due 2032 in Private Offering
Price at Filing: $135.51
Real-time Price: $128.93 info
Change: -$6.58 (-5%) info
Market Cap: $36.414B info
Sentiment: Neutral
View Wiseek Article
A
Jun 25, 2026, 4:23 PM EDT
Filing Type: 8-K
Importance Score:
7
Agilent Technologies Raises $600M in Senior Notes Offering
Price at Filing: $135.51
Real-time Price: $128.93 info
Change: -$6.58 (-5%) info
Market Cap: $36.414B info
Sentiment: Neutral
View Wiseek Article
A
Jun 25, 2026, 8:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Agilent Completes Acquisition of Cancer Diagnostics Firm Biocare Medical
Price at Filing: $131.98
Real-time Price: $128.93 info
Change: -$3.05 (-2%) info
Market Cap: $36.414B info
Sentiment: Neutral
View Wiseek Article
A
Jun 03, 2026, 7:04 AM EDT
Source: Reuters
Importance Score:
7
Agilent Partners with OpenAI, BCG to Drive AI-Powered Scientific Innovation
Price at Filing: $134.92
Real-time Price: $128.93 info
Change: -$5.99 (-4%) info
Market Cap: $36.414B info
Sentiment: Positive
View Wiseek Article
A
Jun 02, 2026, 4:43 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
FDA Expands Agilent's Cancer Test Approval to Four New Tumor Types
Price at Filing: $134.93
Real-time Price: $128.93 info
Change: -$6.00 (-4%) info
Market Cap: $36.414B info
Sentiment: Positive
View Wiseek Article
A
Jun 01, 2026, 4:09 PM EDT
Filing Type: 10-Q
Importance Score:
8
Agilent Reports Strong Q2 2026 Results with Double-Digit Revenue Growth and Significant EPS Increase
Price at Filing: $135.98
Real-time Price: $128.93 info
Change: -$7.05 (-5%) info
Market Cap: $36.414B info
Sentiment: Positive
View Wiseek Article
A
May 27, 2026, 4:06 PM EDT
Filing Type: 8-K
Importance Score:
7
Agilent Reports Strong Q2 Results, Raises Full-Year Revenue and EPS Guidance
Price at Filing: $122.14
Real-time Price: $128.93 info
Change: +$6.79 (+6%) info
Market Cap: $36.414B info
Sentiment: Positive
View Wiseek Article
A
May 27, 2026, 4:05 PM EDT
Source: Reuters
Importance Score:
8
Agilent boosts 2026 profit outlook after Q2 earnings and revenue beat
Price at Filing: $117.57
Real-time Price: $128.93 info
Change: +$11.36 (+10%) info
Market Cap: $36.414B info
Sentiment: Positive
View Wiseek Article
A
Mar 26, 2026, 8:49 AM EDT
Source: dpa-AFX
Importance Score:
7
Agilent Secures Expanded FDA Approval for PD-L1 Diagnostic in Esophageal Cancer
Price at Filing: $113.32
Real-time Price: $128.93 info
Change: +$15.61 (+14%) info
Market Cap: $36.414B info
Sentiment: Positive
View Wiseek Article
A
Mar 20, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Stockholders Approve Board Declassification and New Bylaws
Price at Filing: $111.30
Real-time Price: $128.93 info
Change: +$17.63 (+16%) info
Market Cap: $36.414B info
Sentiment: Positive
View Wiseek Article